Volume change with gantenerumab: Impact of amyloid‐related imaging abnormalities and amyloid removal
- DOI
- 10.1002/alz.71749
- Published
- 2026-08
- Container
- Alzheimer's & Dementia
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/alz.71749,
title = {Volume change with gantenerumab: Impact of amyloid‐related imaging abnormalities and amyloid removal},
author = {Matteo Tonietto and Erica Silvestri and Christopher R. S. Belder and Frederik Barkhof and Nick C. Fox and Janice Smith and Gregory Klein},
year = {2026},
journal = {Alzheimer's \& Dementia},
doi = {10.1002/alz.71749},
url = {https://doi.org/10.1002/alz.71749}
}RIS
TY - JOUR TI - Volume change with gantenerumab: Impact of amyloid‐related imaging abnormalities and amyloid removal AU - Matteo Tonietto AU - Erica Silvestri AU - Christopher R. S. Belder AU - Frederik Barkhof AU - Nick C. Fox AU - Janice Smith AU - Gregory Klein PY - 2026 JO - Alzheimer's & Dementia DO - 10.1002/alz.71749 UR - https://doi.org/10.1002/alz.71749 ER -
APA
Tonietto, M., Silvestri, E., Belder, C. R. S., Barkhof, F., Fox, N. C., Smith, J., & Klein, G. (2026). Volume change with gantenerumab: Impact of amyloid‐related imaging abnormalities and amyloid removal. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71749
Source records
- crossref · retrieved 2026-09-24T16:58:27.554Z